Codexis Logo - September 2023.png
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
November 12, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
November 11, 2024 16:05 ET | Codexis, Inc.
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type...
Codexis Logo - September 2023.png
Codexis Announces New Employment Inducement Grants
November 08, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis to Participate in Upcoming Healthcare Conferences
November 04, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis Reports Third Quarter 2024 Financial Results
October 31, 2024 16:05 ET | Codexis, Inc.
Quarter Highlights Include Key Additions to Management Team and Extension of Cash Runway into 2027 with $31M Raise via ATM Facility Company Reiterates Full-year Financial Guidance; On Track to...
Codexis Logo - September 2023.png
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
October 24, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis Announces New Employment Inducement Grants
October 14, 2024 07:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis to Report Third Quarter 2024 Financial Results on October 31
October 10, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Logo - September 2023.png
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
October 02, 2024 16:05 ET | Codexis, Inc.
Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of...
Codexis Logo - September 2023.png
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
October 01, 2024 07:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and...